PD-L1 expression on circulating epithelial tumor cells (CETCs) is associated with immune evasion and tumor progression in breast cancer patients and differs from PD-L2 expression

被引：0
|
作者：
Lux, D.
机构：
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2018年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-51
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [1] PD-L1 Expression on Circulating Epithelial tumour Cells (CETCS) Is Associated with Immune Evasion and Tumour Progression in Breast Cancer Patients and Differs from PD-L2 Expression
    Schott, Dorothea
    Pizon, Monika
    Pachmann, Ulrich
    Pachmann, Katharina
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 112 - 112
  • [2] PD-L1 expression on circulating epithelial tumor cells (CETCs) correlates with the presence of metastasis in breast cancer patients and differs from PD-L2 expression
    Pizon, Monika
    Schott, Dorothea
    Pachmann, Ulrich
    Pachmann, Katharina
    [J]. CANCER RESEARCH, 2017, 77
  • [3] PD-L1 expression on circulating epithelial tumor cells (CETCs) correlates with aggressiveness of tumor in breast cancer patients
    Schott, D.
    Pizon, M.
    Pachmann, U.
    Pachmann, K.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [4] PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer
    Darga, Elizabeth P.
    Dolce, Emily M.
    Fang, Fang
    Kidwell, Kelley M.
    Gersch, Christina L.
    Kregel, Steven
    Thomas, Dafydd G.
    Gill, Anoop
    Brown, Martha E.
    Gross, Steven
    Connelly, Mark
    Holinstat, Michael
    Cobain, Erin F.
    Rae, James M.
    Hayes, Daniel F.
    Paoletti, Costanza
    [J]. PLOS ONE, 2021, 16 (11):
  • [5] PD-L1 expression on circulating tumor cells and prognosis of breast cancer patients.
    Wang, Xuefei
    Zhang, Goechao
    Sun, Qiang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Assessment of PD-L1 expression in circulating tumor cells in patients with breast cancer.
    Chen, Junqing
    Chen, Zhanhong
    Wang, Xiaojia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] A tumor specific super-enhancer drives immune evasion by guiding synchronous expression of PD-L1 and PD-L2
    Fan, Y.
    Xu, Y.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 402 - 402
  • [8] PD-L2 Expression in Breast Cancer Promotes Tumor Development and Progression
    Sun, Yuling
    Yang, Jie
    Chen, Yachun
    Guo, Yundi
    Xiong, Jian
    Guo, Xuqin
    Zhang, Yawen
    Gu, Li
    Tong, Min
    Wang, Weipeng
    Sun, Jing
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2024, 2024
  • [9] Expression of PD-L1 on circulating epithelial tumor cells (CETCs) in men with primary non-metastatic prostate cancer
    Schott, D.
    Pizon, M.
    Pachmann, K.
    Pachmann, U.
    Maeurer, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1157 - S1157
  • [10] A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2
    Xu, Yuanpei
    Wu, Yingcheng
    Zhang, Siliang
    Ma, Panpan
    Jin, Xinxin
    Wang, Zhou
    Yao, Min
    Zhang, Erhao
    Tao, Baorui
    Qin, Yongwei
    Chen, Hao
    Liu, Aifen
    Chen, Miaomiao
    Xiao, Mingbing
    Lu, Cuihua
    Mao, Renfang
    Fan, Yihui
    [J]. CELL REPORTS, 2019, 29 (11): : 3435 - +
12345